Although, CTNNB1 activation is a canonical driver mutation, a decrease in normal levels of CTNNB1 may also be advantageous to cancer cells as RNAi depletion of CTNNB1 has been shown to increase cell migration [21]. This evidence concerns the gene CTNNB1 and cancer.